drugset / Press release
Novel oral antibiotic treatment SeysaraTM (sarecycline) now available in the U.S.
2019-01-17 · Almirall, S.A. · original almirall.com ↗
Seysara™ is the first oral antibiotic that has been specifically developed for use in acne. It is approved for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients nine years of age and older 1 Two pivotal studies confirmed efficacy of Seysara™at 12 weeks, with reduction of inflammatory acne lesions seen as early as three weeks. Seysara™ has a demonstrated safety profile and is taken once-daily, with or without food.
The release as fetched from its publisher. almirall.com ↗